Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing sales7@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Di-P-Toluoyl-D-Tartaric Acid Monohydrate

    • Product Name Di-P-Toluoyl-D-Tartaric Acid Monohydrate
    • Alias DPTTA Monohydrate
    • Einecs 248-245-6
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry sales7@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    930638

    Name Di-P-Toluoyl-D-Tartaric Acid Monohydrate
    Synonyms DPTTA Monohydrate
    Chemical Formula C20H18O8·H2O
    Molecular Weight 404.38 g/mol
    Appearance White to off-white crystalline powder
    Melting Point 177-181°C
    Solubility Soluble in methanol, ethanol, and acetone; slightly soluble in water
    Optical Rotation [α]D20 +137° (c=1, in methanol)
    Cas Number 71607-32-4
    Storage Temperature Room temperature, dry conditions
    Purity Typically ≥98%
    Application Chiral resolving agent

    As an accredited Di-P-Toluoyl-D-Tartaric Acid Monohydrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing A 25g amber glass bottle with a white screw cap, tamper-evident seal, and label displaying compound details and hazard information.
    Shipping Di-P-Toluoyl-D-Tartaric Acid Monohydrate is shipped in tightly sealed containers to prevent moisture absorption and contamination. It should be transported at ambient temperatures, away from direct sunlight and incompatible substances. Ensure packaging is secure to avoid spillage or breakage during transit. Follow all applicable chemical transport regulations and labeling requirements.
    Storage **Di-P-Toluoyl-D-Tartaric Acid Monohydrate** should be stored in a tightly sealed container, away from moisture and direct sunlight. Keep it in a cool, dry, and well-ventilated area, ideally at room temperature (15–25°C). Ensure it is kept separate from incompatible substances, such as strong oxidizing agents, and follow standard chemical storage protocols for safe handling.
    Application of Di-P-Toluoyl-D-Tartaric Acid Monohydrate

    Applications of Di-P-Toluoyl-D-Tartaric Acid Monohydrate in Industrial Manufacturing

    As a dedicated manufacturer of Di-P-Toluoyl-D-Tartaric Acid Monohydrate, we support a range of specialized industrial applications in chiral chemical synthesis and downstream value chains. The following sections detail verified real-world integration points, highlighting precise compliance parameters, functional dosage guidance, process details, and end-use manufacturers’ product outputs for each scenario.

    1. Chiral Resolution of Pharmaceutical Intermediates

    In active pharmaceutical ingredient (API) synthesis, our product serves as a resolving agent for separating racemic mixtures of basic amine compounds, including key intermediates in beta-blocker and anti-hypertensive drug manufacturing. Formulators adjust addition rates based on substrate complexity and salt-formation characteristics, ensuring rigorous batch consistency and regulatory traceability. The material is introduced during salt-formation steps, facilitating the selective crystallization of target enantiomers, followed by filtration and purification to pharmaceutical-grade specifications. Finished goods downstream include enantiomerically pure intermediates used in further reactions toward major APIs for regulated markets.

    Industry compliance standards

    • ICH Q7 GMP for Active Pharmaceutical Ingredients
    • USP/NF and Ph. Eur. for Chiral Resolution Procedures
    • API manufacturers' internal quality protocols
    • FDA 21 CFR Part 210/211 (cGMP) for downstream APIs

    Typical usage ratio

    • 0.7–1.2 molar equivalents based on racemate input; precise ratio set according to stoichiometry and targeted yield/purity

    Downstream process integration

    • Added post-reaction in chiral salt formation as a resolving agent, followed by enantiomer-specific crystallization and filtration

    Final product types

    • Enantiomerically pure pharmaceutical intermediates for beta-blockers, calcium channel blockers, and CNS drug APIs

    2. Production of Chiral Catalysts for Asymmetric Synthesis

    Chemical manufacturers use our raw material for resolving diamine ligands and other chiral building blocks required in the fabrication of enantioselective catalysts. Its stereospecific interaction enables reliable differentiation of isomers, crucial for downstream catalyst efficacy in large-scale organic synthesis. The product is incorporated at the ligand resolution stage, commonly in fine chemical plants, where purity affects subsequent catalyst performance in asymmetric hydrogenation and C–C bond formation. End users deploy these catalysts across pesticide, fragrance, and drug intermediate synthesis plants.

    Industry compliance standards

    • ISO 9001:2015 Quality Management for chemical processing
    • REACH registration (EU) for manufacturing and handling
    • Responsible Care® program adherence for environmental and safety controls

    Typical usage ratio

    • 1.0–1.5 molar equivalents per diamine or target chiral ligand; variance follows desired enantiomeric excess and solubility in chosen solvent

    Downstream process integration

    • Introduced at the enantiomeric separation stage for ligand resolution, before washing and catalyst assembly

    Final product types

    • Chiral phosphine/amine ligands, chiral catalysts for asymmetric hydrogenation, and specialty chemical reagents

    3. Resolution of Alkaloids in Bulk API Manufacturing

    Our facility supplies this chiral acid to companies isolating and purifying optically active alkaloids such as ephedrine, pseudoephedrine, and related pharmaceutical bases. The acid’s enantiomer discrimination properties help obtain desired optical isomers in industrial-scale crystallizations, providing a robust pathway to meet pharmacopoeial batch standards. It enters the process during alkaloid salt-formation, directly affecting isomeric purity and subsequent filtration yields. Plants manufacturing generic and branded API alkaloids depend on this step for regulatory releases.

    Industry compliance standards

    • Pharmacopoeias: USP, EP, JP (chapter on optical isomerism for APIs)
    • WHO GMP for bulk pharmaceutical production
    • SOPs on chiral separation and process validation

    Typical usage ratio

    • Typically 1:1 molar ratio with the target alkaloid free base; adjustments based on crystallization solvent capacity and desired throughput

    Downstream process integration

    • Dosed after alkaloid base liberation, forming diastereomeric salts, with subsequent slit-filtration and isomer separation

    Final product types

    • Pure (R)- or (S)-ephedrine, pseudoephedrine, and related alkaloid API powders

    4. Manufacturing of Chiral Amino Acid Derivatives

    Amino acid derivative producers employ this material for enantiomeric purification of optically active amines during fine chemical synthesis. Selective salt formation with d-tartaric acid derivatives allows removal of unwanted isomers, improving final enantiomeric excess. The compound is charged during the downstream intermediate crystallization stage, where temperature and solvent control determine recovery rates. This process supports the supply of high-purity intermediates used in peptide drug and specialty monomer production.

    Industry compliance standards

    • ISO 22716 for cosmetic peptide ingredients
    • GMP (EU and FDA) for pharmaceutical amino acid intermediates
    • Client QC specifications for chiral purity (>99% ee)

    Typical usage ratio

    • 1–1.1 equivalents per optically active amine substrate; modified based on batch size and resolution kinetics

    Downstream process integration

    • Implemented at the enantiomeric separation stage immediately before purification, as a time-controlled crystallization step

    Final product types

    • Enantiomerically pure amino acid derivatives, peptide building blocks, N-protected amine intermediates

    5. Chiral Alcohol Resolution in High-Performance Materials

    Advanced polymer and specialty materials manufacturers apply this reagent in optical purity adjustment for chiral alcohols prior to incorporation into light-sensitive polymers and high-value additives. Accurate control over stereochemistry at this stage determines the functional properties of end-use high-performance films, coatings, and specialty resins. The acid enters in post-synthetic crystallization following alcohol synthesis, and downstream processes include ethanol wash, recovery, and resin monomer conversion. The resolved chiral alcohols feed specialty plastics, OLED materials, and optically active adhesives lines.

    Industry compliance standards

    • ISO 14001 for environmental management in materials chemistry
    • REACH registration for specialty monomers
    • Internal optical purity KPIs as set by major film and polymer manufacturers

    Typical usage ratio

    • 0.9–1.1 molar equivalents in alcohol resolution; dosage refined by alcohol chain length and crystallization efficiency

    Downstream process integration

    • Applied after alcohol synthesis, during resolution and pre-polymerization purification

    Final product types

    • Chirally pure alcohol monomers, optically active polymers, OLED base layers, advanced adhesives
    Free Quote

    Competitive Di-P-Toluoyl-D-Tartaric Acid Monohydrate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: sales7@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Discovering Di-P-Toluoyl-D-Tartaric Acid Monohydrate: A Manufacturer's Perspective

    How Production Choices Shape Quality and Purity

    Di-P-Toluoyl-D-Tartaric Acid Monohydrate often ends up on the order lists of companies working in chiral chemistry and analytical laboratories. Its systematic development—through every batch on our production line—reflects both a specialty of fine chemistry and lessons learned from years of hands-on experience. Our understanding of this product runs deeper than its chemical structure. In our plant, we manage crucial variables like temperature, reaction time, choice of solvents, filtration, and drying stages. Each phase holds the potential to change the product’s purity and performance. Years spent refining filtration to avoid carryover or scale-up challenges turn into real results: tight control over stereochemical integrity and crystal morphology. It’s easy to overlook such complexities when only looking at a certificate of analysis, but the difference shows in crystal sharpness and melting point consistency.

    Product Focus: What Is Di-P-Toluoyl-D-Tartaric Acid Monohydrate?

    This compound, known for its use as a resolving agent in chiral chemistry, features two toluoyl groups attached to a tartaric acid core, with one water molecule per formula unit. The water content—integral to the monohydrate form—matters more than some imagine. Water’s presence influences solubility, ease of handling, and shelf stability. Skipping attention to hydration during crystallization steps leads to inconsistent results; tighter control over the drying ovens and atmosphere ensures the product maintains its proper form. The final monohydrate crystals have a practical advantage: better flow properties and manageable dusting in the plant and the end user’s laboratory. With repeated experience, we have adjusted centrifugation speeds and solvent ratios until particle size and texture meet an efficient, reproducible standard.

    Specifications from the Production Floor

    For our Di-P-Toluoyl-D-Tartaric Acid Monohydrate, production always involves fresh starting materials and precise tracking of batch histories. Each lot undergoes analysis—chiral HPLC, melting point, moisture determination, and enantiomeric excess. This hands-on work reveals differences between batches, prompting adjustments on the fly. In practice, the monohydrate form consistently displays a melting point in the expected range, typically between 110°C and 114°C. On the plant floor, we depend on experienced operators who recognize not only the right temperature, but the subtle signs of crystal completion—clarity, granule formation, and the sound of settled product in trays. These nuances won’t appear on standard specification sheets or safety data, yet they shape every kilo packed and labeled.

    Role in Resolving Agents and Stereochemistry

    Most customers relying on Di-P-Toluoyl-D-Tartaric Acid Monohydrate require high performance in chiral separations. Its value rests in its ability to form diastereomeric salts with pharmaceutical intermediates and complex molecules, supporting separation and purification tasks. We’ve witnessed customers struggling with poorly controlled batches from less-experienced producers. Impurities in the resolving agent, or simply the wrong hydration level, disrupt salt formation, create ambiguous melting points, and introduce headaches into downstream purification work. On our end, we’ve implemented inline monitoring, not just batchwise spot checks, to minimize such risks. Quality control is not a theoretical idea but a practical balance among throughput, power use, operator acumen, and quality. The trust scientists place in our product comes from this consistent, hard-earned performance, not from certificates or digital catalogs.

    Differentiating from Racemic and Unhydrated Analogs

    Di-P-Toluoyl-D-Tartaric Acid Monohydrate differs fundamentally from similar-sounding compounds. Its stereochemistry—the configuration of those tartaric acid carbons—dictates its selectivity. Racemic forms or the L-enantiomer offer different salt-forming properties and should not be substituted into the same protocols without consequence. We’ve handled customer requests where mistakes in procurement led to poor separations or lost time. Through these cases, we’ve standardized our labeling, packing, and cross-checking to minimize errors. Another frequent difference arises with the hydration state. Using anhydrous or dihydrate forms can throw off precise measurements and introduce error into molar calculations. We have worked closely with clients in pharmaceutical scale-up to validate that each lot of our monohydrate matches historical performance, avoiding hidden batch-to-batch variability that could derail critical processes.

    Addressing Purity, Stability, and Transparency

    With Di-P-Toluoyl-D-Tartaric Acid Monohydrate, minute variations in trace impurities can spell problems downstream. On the production line, we monitor not only assay and chiral purity but also heavy metals, trace organics, and water content. Unexpected spikes in residual solvents, arising from lack of control during the reaction or inadequate drying, have occasionally crept into other manufacturers’ lots—as discovered by customers seeking new sources after failed validations. Our own trouble-shooting has led us to optimize glassware cleaning, solvent recycling, and packaging atmospheres. Each modification stems from direct observation and repeated testing. Transparency, in our experience, means sharing not just generic specs, but process details that matter—a record of each batch’s history, validated by both in-house and, when needed, independent laboratories.

    Process Control: Lessons from Experience

    Many teams rely on automation and novel analytical techniques. Yet, practical results depend on vigilance and adaptation. For Di-P-Toluoyl-D-Tartaric Acid Monohydrate, age-old issues such as humidity variation, local temperature spikes, and the fatigue of operators after a long shift have caused more problems than any fancy technical debate. We schedule regular breaks for operators during crystallization and offer incentives for lab staff who catch variances early. Process logs record everything from room temperature to operator names. Each season brings new variables—summer heat increases risk of caking, while winter cold promotes uneven drying. Through trial, error, and training, we equip our team to recognize, report, and correct such issues before they ever reach quality assurance.

    Crystallization: Small Details Yield Big Results

    Users often assume that one manufacturer’s Di-P-Toluoyl-D-Tartaric Acid Monohydrate works the same as another’s. Our history tells a different story. Years ago, we refined a slow-cooling crystallization protocol that allows the most stable, sharpest crystals. Fast cooling, on the other hand, led to trapped solvents and irregular particle size. The resulting product attracted moisture and formed clumps in storage. Only through several pilot-plant failures did we develop a routine—with continuous agitation and temperature ramps—that now provides a consistent, dust-free product year-round. New hires learn these techniques during hands-on apprenticeships, ensuring process knowledge passes down the line rather than relying solely on written instructions.

    Delivering Reliable Packaging and Logistics

    Chemicals like Di-P-Toluoyl-D-Tartaric Acid Monohydrate demand careful packaging. Early mistakes—using non-barrier pouches or containers that didn’t completely block moisture—taught us lessons the hard way. The monohydrate form, given improper storage, loses water and shifts its properties subtly but importantly. Shipping conditions differ: short-haul domestic trucks pose less risk than overseas containers exposed to wild temperature swings and humidity. Over time, we introduced triple-seal foil pouches and rigid outer drums, which prevent both water ingress and accidental breakage. Our logistics staff maintains tracking at each node, ready to intervene if delays or customs hold-ups threaten product quality.

    User Support: Beyond the Product Sheet

    Customers in pharmaceuticals and academic labs rarely need a one-size-fits-all approach. Researchers often call with unique solvent systems, challenging separations, or questions about scale-up compatibility. We staff experienced chemists who respond with advice rooted in actual plant experience: how to adapt resolution recipes, what to expect when changing solvation levels, or how to check for subtle degradation during storage. Trust builds through conversations where we share data, discuss learning curves, and sometimes even ship additional reference material to help troubleshoot. In more than one case, real-time collaboration led to improved yields for clients or new applications for our product. We know success ties directly to a willingness to help, not just to sell.

    Environmental Responsibility and Process Safety

    Sustainable operations make an impact both internally and for our customers. Over the past decade, we’ve tuned our Di-P-Toluoyl-D-Tartaric Acid Monohydrate process to lower waste and use greener solvents. Workers receive training in safe handling, and any spills are caught and treated through scrubbers and water-phased containment systems. Where possible, we recycle by-products, reducing the plant’s disposal footprint. Audits from regulatory bodies such as REACH and local ministries push us to greater transparency. These efforts sometimes mean slower production or higher cost, but yield a safer, more stable product. The changes are not theoretical; lower waste and cleaner product batches raise staff morale and improve relationships with neighbors, regulators, and downstream users alike.

    Comparing with Similar Products: More Than Just a Name

    While Di-P-Toluoyl-D-Tartaric Acid Monohydrate is well-known, competitors also offer other tartaric acid derivatives—monoesters, ditoluoyl analogs, or solutions designed for automated chiral HPLC. Customers sometimes ask about switching between monohydrate and anhydrous types to cut weight or match cost targets. Past cases show this can backfire: reaction yields shift, unwanted by-products form, or purification becomes less straightforward. We document each episode, updating recommendations and guiding users based on actual outcomes. Having controlled every aspect from sourcing raw tartaric acid to final packaging means the differences in results are more than theoretical—they show up in actual lab and plant processes. The right choice depends on the end process and how much process risk the user can tolerate.

    Building Trust Through Traceability

    Traceability in specialty chemical manufacture is not an empty phrase. Each batch of Di-P-Toluoyl-D-Tartaric Acid Monohydrate carries a unique identifier linked to a digital record—complete with logs, staff annotations, analytic reports, and any deviations encountered in the process. Clients request detailed batch histories to meet regulatory audits or respond to unexpected results. We learned early that quick access to this data, delivered by knowledgeable staff rather than automated systems, makes all the difference. Traceability supports reliable supply, forms the backbone of corrective actions, and provides confidence for both research and production applications.

    Partnering on Problem-Solving

    New application areas arise regularly—from novel API synthesis projects to analytical method development. Open dialogue with users—before issues arise—sets the stage for better outcomes. Our technical service team fields questions on solvation effects, unusual crystallization behaviors, or new process validation needs. Field reports sometimes reveal side reactions or unexpected compound behaviors. Instead of hiding from these challenges, we engage, analyze, and often adjust production parameters to address the user’s findings. This continuous feedback loop, built on two-way respect, reinforces both process improvement and end-user confidence. Our most satisfied partners rarely fit a standard profile—they value real discussion over packaged promises.

    Innovation in Production Technology

    Over the years, we’ve invested in semi-automated reactors, advanced filtration, and inline moisture sensors for manufacturing Di-P-Toluoyl-D-Tartaric Acid Monohydrate. Investments often spring from failures or near-misses: a process running out of control, an unexpected impurity traced to a valve malfunction. Learning from mistakes drives the team to propose, pilot, and eventually scale up improvements—sometimes leading to entirely new standard operating procedures. These investments raise consistency, cut down turnaround times, and help us anticipate shifting industry requirements. Rather than clinging to convention, we reward process suggestions from every corner of the company—producing a real culture of improvement that underpins our reputation for quality.

    User Experience: Results in the Laboratory

    Lab-scale researchers judge quality fast. Effective Di-P-Toluoyl-D-Tartaric Acid Monohydrate provides distinct, unambiguous separation in chiral resolution experiments, with minimal baseline drift on HPLC and clear melting transitions. We hear immediately from users when batches deviate in appearance, performance, or even smell. Each complaint prompts not just a replacement, but a review of logs and often—if warranted—process retesting. Process feedback from analytical labs pushes us to re-evaluate aging, packaging, and handling. These adjustments translate into higher confidence for future shipments. For researchers trying to isolate novel compounds, even a small change in resolving agent properties can mean wasted time or lost project funding. As a result, we sharpen batch-to-batch reproducibility.

    The Value of Long-Term Relationships

    True progress in chemical manufacture comes from long-term relationships. Repeat customers have taught us as much about our Di-P-Toluoyl-D-Tartaric Acid Monohydrate as we have from batch records. Their challenges inform our upgrades; their feedback steers our process changes; and their trust cements our motivation to adjust specifications, packaging, or documentation on demand. By inviting regular plant visits and fostering open calls for comment, we build both transparency and shared investment in performance. Stability in our supply chain allows R&D partners to focus on their science rather than risk management. These shared gains pile up year after year, supporting not just innovation, but scientific and business progress.

    Meeting Regulatory Demands

    Rising regulatory expectations shape every aspect of fine chemical manufacturing. From initial raw material sourcing through process audit documentation, compliance dominates discussions about Di-P-Toluoyl-D-Tartaric Acid Monohydrate’s use in pharmaceuticals and specialty chemistry. We took early steps to align with global standards—tracking provenance, validating analytical procedures, and standardizing documentation. Regulators expect not just basic certificates, but robust, verified records linking every lot to detailed lab, plant, and packaging procedures. Our team prepares for inspection with well-kept archives, readily accessible batch histories, and a willingness to supply additional validation or method data. Meeting these standards directly benefits customers facing their own audit and approval challenges.

    Continuous Improvement in Manufacturing Practice

    Innovation rarely stops at product launch. Adjustments in reaction timing, the introduction of lower-energy equipment, and the adoption of new analytical techniques have all been driven by experience with Di-P-Toluoyl-D-Tartaric Acid Monohydrate. Our operators recommend changes, and technical leads validate suggestions with pilot runs before incorporating a revised protocol into routine production. Detailed end-to-end knowledge—chemistry, equipment, operator insight, and feedback from customer sites—yields continuous gains in quality and durability. We avoid resting on process knowledge that risks becoming stale.

    Attention to Storage and Shelf Life

    Di-P-Toluoyl-D-Tartaric Acid Monohydrate, even when produced tightly to specification, reacts to storage conditions. Lab experience shows that temperature swings or excess humidity alter solvation and particle integrity. Years ago, we implemented regular stability sampling, pulling legacy lots from finished goods stores for repeat testing. This approach, born of one unexpected spoilage incident in a warehouse, has become routine. Each test guides improvements: revised storage recommendations, improved packaging barriers, or altered temperature control settings for warehousing. Experience has shown no shortcut replaces diligence in storage.

    Field Collaboration and Real-Time Feedback

    Direct feedback from users, coupled with proactive outreach, improves both process and product. Periodic surveys and targeted follow-ups uncover unanticipated bottlenecks and foster new development projects. Technical partners using Di-P-Toluoyl-D-Tartaric Acid Monohydrate in method development or scale-up share not only praise but real troubleshooting requests. We encourage these exchanges—knowing that no written protocol can cover every application. Through joint efforts, we flag trends (such as recovery yields or new analytical artifacts) and adhere to a process for swift solution development. Many on our technical team maintain ongoing conversations, growing real expertise in field use and generating tangible process improvements.

    Summary: Lessons Learned in Manufacturing Excellence

    Decades of experience making Di-P-Toluoyl-D-Tartaric Acid Monohydrate have shaped every element: process rigor, raw material screening, close monitoring of hydration and stereochemistry, practical attention to storage, packaging customization, and collaborative, informed customer support. Our knowledge—earned through production experience, technical investigation, and user partnership—translates into a more consistent, reliable product. Customers who rely on clear separation, robust scale-up, or tailored analytical work benefit from attention to every production and logistics detail. Continuous learning keeps us ahead: each mistake informs a new protocol, each success strengthens the partnership. Our factory lessons become the foundation for lasting trust with every delivery.